Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The evolution and clinical impact of hepatitis B virus genome diversity
Peter Revill, Thomas Tu, Hans Netter, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 10, pp. 618-634
Closed Access | Times Cited: 136

Showing 1-25 of 136 citing articles:

From hepatitis A to E: A critical review of viral hepatitis
Daniel Castañeda, Adalberto Gonzalez, Mohammad Alomari, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 16, pp. 1691-1715
Open Access | Times Cited: 117
Hepatitis B Virus-Associated Hepatocellular Carcinoma
Giacomo Emanuele Maria Rizzo, Giuseppe Cabibbo, Antonio Craxı̀
Viruses (2022) Vol. 14, Iss. 5, pp. 986-986
Open Access | Times Cited: 116
New Approaches to Chronic Hepatitis B
Geoffrey Dusheiko, Kosh Agarwal, Mala K. Maini
New England Journal of Medicine (2023) Vol. 388, Iss. 1, pp. 55-69
Open Access | Times Cited: 100
Inferring effects of mutations on SARS-CoV-2 transmission from genomic surveillance data
Brian Lee, Ahmed Abdul Quadeer, Muhammad S. Sohail, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Viral hepatitis and pregnancy
Norah A. Terrault, Miriam Levy, Ka Wang Cheung, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 18, Iss. 2, pp. 117-130
Closed Access | Times Cited: 111
HBV-Integration Studies in the Clinic: Role in the Natural History of Infection
Teresa Pollicino, Giuseppe Caminiti
Viruses (2021) Vol. 13, Iss. 3, pp. 368-368
Open Access | Times Cited: 94
The role of cGAS-STING signalling in liver diseases
Ruihan Chen, Jiamin Du, Hong Zhu, et al.
JHEP Reports (2021) Vol. 3, Iss. 5, pp. 100324-100324
Open Access | Times Cited: 68
Validation Study of Scores Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Treated With Nucleos(t)ide Analogues
Jun Inoue, Shinichiro Minami, Kazumichi Abe, et al.
Journal of Viral Hepatitis (2025) Vol. 32, Iss. 4
Open Access | Times Cited: 1
De novo synthesis of hepatitis B virus nucleocapsids is dispensable for the maintenance and transcriptional regulation of cccDNA
Thomas Tu, Benno Zehnder, Bingqian Qu, et al.
JHEP Reports (2020) Vol. 3, Iss. 1, pp. 100195-100195
Open Access | Times Cited: 51
Hepatitis B Virus DNA Integration, Chronic Infections and Hepatocellular Carcinoma
Maria Bousali, George Papatheodoridis, Dimitrios Paraskevis, et al.
Microorganisms (2021) Vol. 9, Iss. 8, pp. 1787-1787
Open Access | Times Cited: 41
PIN1 and PIN4 inhibition via parvulin impeders Juglone, PiB, ATRA, 6,7,4′-THIF, KPT6566, and EGCG thwarted hepatitis B virus replication
Umar Saeed, Zahra Zahid Piracha
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 18
Uptake pathways of cell-penetrating peptides in the context of drug delivery, gene therapy, and vaccine development
Moataz Dowaidar
Cellular Signalling (2024) Vol. 117, pp. 111116-111116
Closed Access | Times Cited: 8
Inflammatory Response in the Pathogenesis and Treatment of Hepatocellular Carcinoma: A Double-Edged Weapon
Linda Galasso, Lucia Cerrito, Valeria Maccauro, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7191-7191
Open Access | Times Cited: 6
Comprehensive Analysis of Clinically Significant Hepatitis B Virus Mutations in Relation to Genotype, Subgenotype and Geographic Region
Natalia M. Araújo, Sheila Araújo Teles, Natália Spitz
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 44
The Hepatitis B Virus Nucleocapsid—Dynamic Compartment for Infectious Virus Production and New Antiviral Target
Matthias Niklasch, Peter Jan Zimmermann, Michael Nassal
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1577-1577
Open Access | Times Cited: 38
Potential of cell-penetrating peptides (CPPs) in delivery of antiviral therapeutics and vaccines
Issa Sadeghian, Reza Heidari, Sara Sadeghian, et al.
European Journal of Pharmaceutical Sciences (2021) Vol. 169, pp. 106094-106094
Open Access | Times Cited: 38
Countdown on hepatitis B elimination by 2030: the global burden of liver disease related to hepatitis B and association with socioeconomic status
Guiying Cao, Wenzhan Jing, Jue Liu, et al.
Hepatology International (2022) Vol. 16, Iss. 6, pp. 1282-1296
Closed Access | Times Cited: 24
Hepatitis B virus DNA integration as a novel biomarker of hepatitis B virus-mediated pathogenetic properties and a barrier to the current strategies for hepatitis B virus cure
Romina Salpini, Stefano D′Anna, Livia Benedetti, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 24
Drug Resistance: An Incessant Fight against Evolutionary Strategies of Survival
Francisco Ramos‐Martín, Nicola D’Amelio
Microbiology Research (2023) Vol. 14, Iss. 2, pp. 507-542
Open Access | Times Cited: 14
The role of nitric oxide synthase/ nitric oxide in infection-related cancers: Beyond antimicrobial activity
Xudong Hu, Yueshuo Li, Ya Cao, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189156-189156
Closed Access | Times Cited: 5
Molecular Mechanisms during Hepatitis B Infection and the Effects of the Virus Variability
Marina Campos-Valdez, Hugo Christian Monroy-Ramírez, Juan Armendáriz‐Borunda, et al.
Viruses (2021) Vol. 13, Iss. 6, pp. 1167-1167
Open Access | Times Cited: 27
Comparison of the prevalence of Domestic Cat Hepadnavirus in a population of cats with uveitis and in a healthy blood donor cat population in the United Kingdom
Emily C. Jeanes, Michaela Wegg, Judy A. Mitchell, et al.
Veterinary Ophthalmology (2021) Vol. 25, Iss. 2, pp. 165-172
Closed Access | Times Cited: 27
Cell penetrating peptide: A potent delivery system in vaccine development
Behnam Hasannejad-Asl, Farkhondeh Pooresmaeil, Shahla Takamoli, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 21
Emerging Therapies for Chronic Hepatitis B and the Potential for a Functional Cure
Ming‐Ling Chang, Yun‐Fan Liaw
Drugs (2023) Vol. 83, Iss. 5, pp. 367-388
Closed Access | Times Cited: 12
PTEN deficiency potentiates HBV-associated liver cancer development through augmented GP73/GOLM1
Fuqiang Huang, Jing Guo, Na Zhao, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top